Reply to T.-H. Wang et al.
Publication
, Journal Article
Yang, C-FJ; Chan, DY; Wang, X; D'Amico, TA; Harpole, DH; Berry, MF
Published in: J Clin Oncol
January 2017
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
January 2017
Volume
35
Issue
1
Start / End Page
118 / 120
Location
United States
Related Subject Headings
- Small Cell Lung Carcinoma
- Postoperative Period
- Oncology & Carcinogenesis
- Lung Neoplasms
- Humans
- Combined Modality Therapy
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Yang, C.-F., Chan, D. Y., Wang, X., D’Amico, T. A., Harpole, D. H., & Berry, M. F. (2017). Reply to T.-H. Wang et al. J Clin Oncol, 35(1), 118–120. https://doi.org/10.1200/JCO.2016.68.6980
Yang, Chi-Fu Jeffrey, Derek Y. Chan, Xiaofei Wang, Thomas A. D’Amico, David H. Harpole, and Mark F. Berry. “Reply to T.-H. Wang et al.” J Clin Oncol 35, no. 1 (January 2017): 118–20. https://doi.org/10.1200/JCO.2016.68.6980.
Yang C-FJ, Chan DY, Wang X, D’Amico TA, Harpole DH, Berry MF. Reply to T.-H. Wang et al. J Clin Oncol. 2017 Jan;35(1):118–20.
Yang, Chi-Fu Jeffrey, et al. “Reply to T.-H. Wang et al.” J Clin Oncol, vol. 35, no. 1, Jan. 2017, pp. 118–20. Pubmed, doi:10.1200/JCO.2016.68.6980.
Yang C-FJ, Chan DY, Wang X, D’Amico TA, Harpole DH, Berry MF. Reply to T.-H. Wang et al. J Clin Oncol. 2017 Jan;35(1):118–120.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
January 2017
Volume
35
Issue
1
Start / End Page
118 / 120
Location
United States
Related Subject Headings
- Small Cell Lung Carcinoma
- Postoperative Period
- Oncology & Carcinogenesis
- Lung Neoplasms
- Humans
- Combined Modality Therapy
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences